Alexithymia and Cutaneous Disease Morbidity: A Systematic Review

    January 2022 in “ Dermatology
    Arthur H. Holmes, Pooja Marella, Carlos Rodrı́guez, Donald A. Glass, Katharina S. Goerlich
    Image of study
    TLDR People with certain skin diseases often have more trouble understanding and describing their emotions, which can affect their health and treatment results.
    The systematic review titled "Alexithymia and Cutaneous Disease Morbidity" conducted by Alexis Holmes et al. in 2022, investigated the prevalence of alexithymia (a psychological construct that describes difficulty in understanding and describing one's own emotions) in dermatology patients and its impact on disease burden, psychosocial comorbidities, and treatment. The review used data from 37 publications and found a significantly higher prevalence and severity of alexithymia in patients with alopecia, vitiligo, psoriasis, hidradenitis suppurativa, atopic dermatitis, chronic idiopathic urticaria, and primary focal hyperhidrosis compared to healthy controls. The data also showed a complex relationship between alexithymia, disease burden, and psychosocial comorbidity. The review concluded that identifying and addressing alexithymia in dermatology patients could improve treatment outcomes, associated comorbidities, and health-related quality of life.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community 1 Month Topical Minoxidil Only

      in Progress Pictures  72 upvotes 1 year ago
      The conclusion of the conversation is that the user plans to use topical minoxidil, ketoconazole shampoo, and a derma stamp for hair loss treatment. They also plan to start using finasteride in the next 2 months. Other users suggest using finasteride and a hair transplant for better results. The user appreciates the feedback and will continue posting progress.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 7 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community fin 0.5 mg everday 6 months update

      in Finasteride/Dutasteride  28 upvotes 1 year ago
      The post discusses the experiences of individuals with diffuse hair thinning using finasteride, with many reporting no improvement or worsening conditions after 6 months. Various suggestions include persisting with the treatment, checking for underlying conditions, adding minoxidil for volume, adjusting dosage, and considering other potential causes like autoimmune responses and inflammation.

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

    Similar Research

    6 / 1000+ results